Results 11 to 20 of about 74,143 (357)
Dabigatran‐induced esophagitis with full circumferential blue pigmentation [PDF]
DEN Open, 2023 Dabigatran is a useful and widely used drug for stroke prevention in patients with atrial fibrillation. However, it has been reported to cause esophagitis.
Tomonori Araki +7 more
doaj +2 more sources
Histomorphological and Immunophenotypic Features of Pill-Induced Esophagitis. [PDF]
PLoS ONE, 2015 The aim of this study was to investigate histomorphological and immunophenotypic features in pill-induced esophagitis. We comparatively evaluated the histomorphological, immunophenotypic features of pill-induced esophagitis vs.
Ji Won Kim +7 more
doaj +1 more source
Case Reports in Gastroenterology, 2021 Esophagitis is described as an inflammation of the esophagus and can result from multiple etiologies. Esophageal squamous cell carcinoma (ESCC), presenting as diffuse esophagitis in the absence of a mass or lesion, is rare. We present a case of a 61-year-
Hafsa Abbas +4 more
doaj +1 more source
Esophagitis in a high H. pylori prevalence area: severe disease is rare but concomitant peptic ulcer is frequent. [PDF]
PLoS ONE, 2011 BACKGROUND: Few data are available on the prevalence of erosive and severe esophagitis in Western countries. OBJECTIVE: To retrospectively determine the prevalence and the factors predicting erosive esophagitis and severe esophagitis in a large series of
Julio Ponce +5 more
doaj +1 more source
Esophageal microflora in esophageal diseases
Frontiers in Cellular and Infection Microbiology, 2023 With the development of endoscopic technology, an increasing number of patients with esophageal disease are being diagnosed, although the underlying pathogenesis of many esophageal diseases remains unclear. In recent years, a large number of studies have demonstrated that the occurrence and development of various intestinal diseases were related to ...
Qian Zou +4 more
openaire +3 more sources
First Therapeutic Approval for Eosinophilic Esophagitis
Gastroenterology Insights, 2022 Eosinophilic esophagitis (EE) is a chronic, immune-mediated or antigen-mediated esophageal disease. Treatment for patients with EE can be challenging with no previously approved medications.
Rami A. Al-Horani, Raquel Chiles
doaj +1 more source
Histologically confirmed upper gastrointestinal Crohn’s disease: is it rare or are we just not searching hard enough? [PDF]
Intestinal Research, 2020 Background/Aims Crohn’s disease (CD) may involve the upper parts of the gastrointestinal (GI) tract including the esophagus, stomach, and duodenum. Clinical features of upper GI CD (UGICD) are not well characterized in the Gulf region. We therefore aimed
Omar Ibrahim Saadah +11 more
doaj +1 more source
Endocytoscopic Observation of Esophageal Lesions: Our Own Experience and a Review of the Literature
Diagnostics, 2022 This review outlines the process of the development of the endocytoscope (EC) with reference to previously reported studies including our own. The EC is an ultra-high-magnification endoscope capable of imaging at the cellular level.
Youichi Kumagai +10 more
doaj +1 more source
Eosinophilic esophagitis and esophageal microbiota
Frontiers in Cellular and Infection Microbiology, 2023 Eosinophilic esophagitis (EoE) is an antigen-mediated chronic inflammatory disease of the esophagus, the prevalence of which has steadily increased in recent years. The pathogenesis of EoE is not yet well-defined; however, recent studies have demonstrated that the esophageal microbiota is an essential regulator of physiological and pathological ...
Xiaohan Zhang +4 more
openaire +3 more sources
Inflammatory Intestinal Diseases, 2021 Introduction: Faecal calprotectin (FC) is commonly used as a diagnostic tool for patients with gastrointestinal (GI) symptoms. However, there is uncertainty in daily clinical practice how to interpret an elevated FC in patients with a normal colonoscopy.
Henrik Hovstadius +2 more
doaj +1 more source